{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:40:40Z","timestamp":1791265240364,"version":"4.1.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jcrsjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jcrs.2016.10.017","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T08:45:56Z","timestamp":1482223556000},"page":"1730-1741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Dose and administration of intracameral moxifloxacin for prophylaxis of postoperative endophthalmitis"],"prefix":"10.1097","volume":"42","author":[{"given":"Steve A.","family":"Arshinoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Modabber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-7-20210210","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jcrs.2013.11.002","article-title":"Adoption of intracameral antibiotic prophylaxis of endophthalmitis following cataract surgery; update on the ESCRS Endophthalmitis Study.","volume":"40","author":"Barry","year":"2014","journal-title":"J Cataract Refract Surg"},{"key":"R4-7-20210210","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jcrs.2007.02.032","article-title":"Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.","volume":"33","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R6-7-20210210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jcrs.2012.10.037","article-title":"Six-year incidence of endophthalmitis after cataract surgery: Swedish national study.","volume":"39","author":"Friling","year":"2013","journal-title":"J Cataract Refract Surg"},{"key":"R7-7-20210210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jcrs.2006.09.015","article-title":"Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery.","volume":"33","author":"Ong-Tone","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R9-7-20210210","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0886-3350(01)01270-6","article-title":"Prophylactic intracameral cefuroxime; evaluation of safety and kinetics in cataract surgery.","volume":"28","author":"Montan","year":"2002","journal-title":"J Cataract Refract Surg"},{"key":"R10-7-20210210","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jcrs.2008.12.023","article-title":"Prophylactic intracameral cefazolin after cataract surgery; endophthalmitis risk reduction and safety results in a 6-year study.","volume":"35","author":"Garat","year":"2009","journal-title":"J Cataract Refract Surg"},{"key":"R11-7-20210210","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jcrs.2005.12.135","article-title":"Intracameral cefazolin as prophylaxis against endophthalmitis in cataract surgery.","volume":"32","author":"Romero","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"R12-7-20210210","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jcrs.2009.08.023","article-title":"Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery; ten-year comparative study.","volume":"36","author":"Garcia-Saenz","year":"2010","journal-title":"J Cataract Refract Surg"},{"key":"R13-7-20210210","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.jcrs.2012.09.004","article-title":"Endophthalmitis prophylaxis with intracameral cefuroxime in South Africa.","volume":"38","author":"van der Merwe","year":"2012","journal-title":"J Cataract Refract Surg"},{"key":"R14-7-20210210","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.jcrs.2012.03.024","article-title":"Intracameral cefuroxime injection at the end of cataract surgery to reduce the incidence of endophthalmitis: French study.","volume":"38","author":"Barreau","year":"2012","journal-title":"J Cataract Refract Surg"},{"key":"R16-7-20210210","first-page":"866","article-title":"Endophthalmitis after cataract surgery; a nationwide prospective study evaluating incidence in relation to incision type and location.","volume":"114","author":"Lundstrom","year":"2007","journal-title":"Ophthalmology"},{"key":"R17-7-20210210","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jcrs.2012.07.031","article-title":"Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department.","volume":"39","author":"Shorstein","year":"2013","journal-title":"J Cataract Refract Surg"},{"key":"R18-7-20210210","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jcrs.2011.06.036","article-title":"Incidence of postoperative endophthalmitis after immediate sequential bilateral cataract surgery.","volume":"37","author":"Arshinoff","year":"2011","journal-title":"J Cataract Refract Surg"},{"key":"R19-7-20210210","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ophtha.2015.08.023","article-title":"Endophthalmitis occurring after cataract surgery; outcomes of more than 480,000 cataract surgeries, epidemiologic features, and risk factors.","volume":"123","author":"Jabbarvand","year":"2016","journal-title":"Ophthalmology"},{"key":"R20-7-20210210","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jcrs.2014.05.038","article-title":"Reevaluating intracameral cefuroxime as a prophylaxis against endophthalmitis after cataract surgery in India.","volume":"41","author":"Sharma","year":"2015","journal-title":"J Cataract Refract Surg"},{"key":"R24-7-20210210","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0886-3350(01)01269-X","article-title":"Prophylactic intracameral cefuroxime; efficacy in preventing endophthalmitis after cataract surgery.","volume":"28","author":"Montan","year":"2002","journal-title":"J Cataract Refract Surg"},{"key":"R25-7-20210210","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00055735-200408000-00007","article-title":"Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections.","volume":"15","author":"Mah","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"R26-7-20210210","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9394(02)01334-X","article-title":"Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.","volume":"133","author":"Mather","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R27-7-20210210","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0002-9394(03)00294-0","article-title":"Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.","volume":"136","author":"Kowalski","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"suppl 2","key":"R30-7-20210210","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.survophthal.2004.01.004","article-title":"Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones.","volume":"49","author":"Hwang","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"R31-7-20210210","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.ophtha.2005.06.017","article-title":"Aqueous penetration and biological activity of moxifloxacin 0.5 ophthalmic solution and gatifloxacin 0.3 solution in cataract surgery patients.","volume":"112","author":"Kim","year":"2005","journal-title":"Ophthalmology"},{"key":"R33-7-20210210","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0955-3681(13)80228-6","article-title":"DeBrof. Prophylactic intracameral antibiotics during cataract surgery: the incidence of endophthalmitis and corneal endothelial cell loss.","volume":"6","author":"Gimbel","year":"1994","journal-title":"Eur J Implant Refract Surg"},{"key":"R34-7-20210210","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0002-9394(00)00955-7","article-title":"Vancomycin prophylaxis and emerging resistance: are ophthalmologists the villains? The heros?","volume":"131","author":"Gordon","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R35-7-20210210","first-page":"25","article-title":"Med Lett Drugs T","volume":"46","year":"2004","journal-title":"her"},{"key":"R36-7-20210210","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ophtha.2015.03.016","article-title":"Postoperative hemorrhagic occlusive retinal vasculitis; expanding the clinical spectrum and possible association with vancomycin.","volume":"122","author":"Witkin","year":"2015","journal-title":"Ophthalmology"},{"key":"R42-7-20210210","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1128\/AAC.31.8.1210","article-title":"Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.","volume":"31","author":"Stratton","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"R43-7-20210210","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jcrs.2007.06.026","article-title":"Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin.","volume":"33","author":"OBrien","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R44-7-20210210","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jcrs.2010.06.070","article-title":"Penetration and effectiveness of prophylactic fluoroquinolones in experimental methicillin-sensitive or methicillin-resistant Staphylococcus aureus anterior chamber infections.","volume":"36","author":"Balzli","year":"2010","journal-title":"J Cataract Refract Surg"},{"key":"R45-7-20210210","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/archopht.124.4.479","article-title":"In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates.","volume":"124","author":"Miller","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"R46-7-20210210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00417-012-2098-1","article-title":"Bag and chamber flushing: a new method of using intracameral moxifloxacin to irrigate the anterior chamber and the area behind the intraocular lens.","volume":"251","author":"Matsuura","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R49-7-20210210","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1586\/14787210.1.3.363","article-title":"Moxifloxacin (Avelox): a novel fluoroquinolone with a broad spectrum of activity.","volume":"1","author":"Caeiro","year":"2003","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R50-7-20210210","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1185\/030079906X132668","article-title":"The effect of moxifloxacin on the normal human cornea.","volume":"22","author":"Donaldson","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"R51-7-20210210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ajo.2004.02.051","article-title":"Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model.","volume":"138","author":"Kowalski","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R52-7-20210210","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ajo.2005.04.015","article-title":"Intracameral Vigamox (moxifloxacin 0.5) is non-toxic and effective in preventing endophthalmitis in a rabbit model.","volume":"140","author":"Kowalski","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R54-7-20210210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ajo.2005.02.037","article-title":"The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy.","volume":"140","author":"Burka","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R55-7-20210210","first-page":"24","article-title":"In brief: hypo- and hyperglycemia with gatifloxacin (Tequin).","volume":"48","year":"2006","journal-title":"Med Lett Drugs Ther"},{"key":"R56-7-20210210","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.jcrs.2008.05.034","article-title":"Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery.","volume":"34","author":"Lane","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"R57-7-20210210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcrs.2006.09.019","article-title":"Safety of prophylactic intracameral moxifloxacin 0.5 ophthalmic solution in cataract surgery patients.","volume":"33","author":"Espiritu","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R58-7-20210210","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jcrs.2008.03.017","article-title":"Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery.","volume":"34","author":"Arbisser","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"R60-7-20210210","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jcrs.2005.07.026","article-title":"Vancomycin dilution error.","volume":"31","author":"Fry","year":"2005","journal-title":"J Cataract Refract Surg"},{"key":"R61-7-20210210","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ophtha.2015.09.037","article-title":"Efficacy of intracameral moxifloxacin endophthalmitis prophylaxis at Aravind Eye Hospital.","volume":"123","author":"Haripriya","year":"2016","journal-title":"Ophthalmology"},{"key":"R62-7-20210210","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.jcrs.2013.05.036","article-title":"Efficacy and safety of prophylactic intracameral moxifloxacin injection in Japan.","volume":"39","author":"Matsuura","year":"2013","journal-title":"J Cataract Refract Surg"}],"container-title":["Journal of Cataract and Refractive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335016305193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335016305193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.jcrs.2016.10.017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T14:28:08Z","timestamp":1623767288000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/02158034-201612000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jcrs.2016.10.017","relation":{},"ISSN":["0886-3350"],"issn-type":[{"value":"0886-3350","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose and administration of intracameral moxifloxacin for prophylaxis of postoperative endophthalmitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cataract & Refractive Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrs.2016.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 ASCRS and ESCRS Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}